-+ 0.00%
-+ 0.00%
-+ 0.00%

OPKO HEALTH’S MODEX THERAPEUTICS BEGINS CLINICAL TRIAL OF TETRASPECIFIC ANTIBODY FOR TREATMENT OF B-CELL LYMPHOMAS

Reuters·04/22/2026 12:00:00

Please log in to view news